Veterinary Orthopedic Implants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The veterinary orthopedic implants market size was valued at USD 350.26 million in 2025 and is estimated to grow from USD 378.11 million in 2026 to reach USD 554.28 million by 2031, at a CAGR of 7.95% during the forecast period (2026-2031). This report is Segmented by Product Type (Plates [Locking Compression Plates, and More], Screws, Pins & Wires, and More), Animal Type (Dog, Cat, and More), Material Type (Titanium, Stainless Steel, and More), Application (Trauma Fixation, Joint Replacement, and More), End User (Veterinary Hospitals, and More), and Geography (North America, and More). Forecasts are Provided in Value (USD).

Global Veterinary Orthopedic Implants Market Trends and Insights

Rising Companion Animal Orthopedic Caseload

The Veterinary orthopedic implants market is being lifted by a larger companion animal population and by longer pet lifespans that increase the incidence of degenerative musculoskeletal disease. The American Veterinary Medical Association reported that 58.6% of U.S. households owned a pet in 2025, up from 56.8% a decade earlier, and the dog-owning base reached 71 million U.S. households in 2025 after a net addition of 4 million households in 1 year. The same structural expansion matters clinically because a larger household base does not just mean more pets, it also means more animals reaching ages where cruciate disease, dysplasia, and age-related fracture risk become more common.

The Veterinary orthopedic implants market also benefits from the fact that improved routine veterinary care is keeping dogs and cats alive longer, which raises the probability of later-life fixation and reconstruction procedures over each animal’s lifetime. This demand is especially concentrated in medium-to-large breed dogs, where cranial cruciate ligament disease and hip dysplasia continue to generate a high share of elective orthopedic referrals. As the case load expands faster than specialist capacity in several regions, the Veterinary orthopedic implants market is favoring standardized systems that shorten decision time and help surgeons move through a larger caseload with more predictable technique selection.

Expansion Of Referral-Grade Surgical Capability

The Veterinary orthopedic implants market is also advancing because more referral-grade capability is reaching secondary cities and suburban catchments that previously sent many orthopedic cases untreated or managed conservatively. Vimian Group stated in its 2024 Annual Report that only 1 in 3 dogs requiring cruciate ligament surgery currently receives the procedure, which shows that access expansion still has room to convert unmet need into active procedural demand. The same report noted that Movora trained 5,150 veterinary professionals through on-site surgery workshops and supported nearly 4,000 online learners in 2024, which shows how training is being used as a commercial growth tool as well as a clinical enabler. This education model matters because surgeons who learn standardized methods at referral centers often carry those methods into general or mixed specialty settings, which gradually widens the treated population.

The Veterinary orthopedic implants market gains from that diffusion because it expands the installed base of surgeons comfortable with premium plate, screw, and procedure-specific systems. It also creates lasting vendor preference, since implant design, instrumentation, and training tend to be adopted together rather than as separate buying decisions.

High Procedure Cost Versus Animal Economic Value

Procedure affordability remains one of the clearest limits on the Veterinary orthopedic implants market because common orthopedic surgeries often cost far more than many owners are prepared to spend without reimbursement support. NAPHIA’s benchmark ranges place TPLO surgery at USD 4,000 to USD 8,000 and orthopedic surgery for ACL and hip conditions at USD 3,000 to USD 7,000, which keeps a large part of demand exposed to out-of-pocket resistance. This cost pressure is sharper in lower-income settings and in cases where owners compare treatment expense with the perceived economic value of the animal, especially outside affluent urban companion animal markets. Vimian Group’s 2024 Annual Report estimated that only 1 in 3 dogs requiring cruciate surgery currently receives treatment, which shows how far realized procedure volume still sits below biological need.

The Veterinary orthopedic implants market therefore loses volume not because clinical solutions are absent, but because owner approval breaks down at the point where benefit, cost, and emotional value are weighed together. Suppliers and hospitals that offer tiered treatment pathways or work more closely with insurers are better placed to unlock that deferred demand without forcing a broad move down the pricing curve.

Other drivers and restraints analyzed in the detailed report include:

• 3D Printed Patient-Specific Implants And Guides
• Growth In Pet Insurance Reimbursement For Orthopedic Care
• Limited Specialist Surgeon Availability Outside Major Cities

Segment Analysis

Plates accounted for 38.31% of revenue in 2025, giving them the leading position across product categories in the Veterinary orthopedic implants market. Their lead reflects broad utility across fracture fixation, corrective osteotomy, and tibial realignment, where surgeons need predictable fixation across many case types. Locking compression plates and TPLO-specific plate designs continue to anchor a large share of this revenue because they align with procedure standardization and support stable fixation in high-volume canine cases. Within the Veterinary orthopedic implants industry, plates remain the foundational inventory line for hospitals and referral surgeons because they support both routine trauma and more advanced reconstructive work. That installed-base advantage matters because once a team is trained around a plate family and its instrumentation, purchasing behavior tends to remain sticky.

Screws are projected to grow at a 10.38% CAGR through 2031, making them the fastest-growing product type in the Veterinary orthopedic implants market. Demand is being lifted by locking and cannulated variants that fit minimally invasive TPLO and TTA workflows and support lower-profile fixation in increasingly standardized procedures. Surgeons also value screws for their compatibility with closed-reduction methods, which can reduce periosteal disruption and support faster bone consolidation in selected cases. A 2026 study in Veterinary and Comparative Orthopaedics and Traumatology found meaningful variability in tibial plateau angle maintenance and bone healing outcomes when a 3.5 mm TPLO locking compression plate was used in dogs weighing 45 to 70 kg, which underlines the engineering challenge of adapting standard hardware across large-breed anatomy. Beyond the leading lines, pins and wires still hold an important role in small-animal fracture management, while joint replacement implants sit in a premium, lower-volume tier that grows as specialist capability matures.

Dogs contributed 67.24% of revenue by animal type in 2025, which makes them the core demand driver in the Veterinary orthopedic implants market. That dominance is tied to the size of the canine patient pool and to the high orthopedic burden seen in medium-to-large breeds prone to cruciate ligament disease, hip dysplasia, and trauma-related fractures. Dog cases also tend to produce more revenue per treated animal because they more often involve high-value stabilization or reconstruction procedures rather than purely conservative management. The American Veterinary Medical Association reported a U.S. dog population of 87.3 million, which reinforces why the canine base remains the commercial center of the Veterinary orthopedic implants market. Within the Veterinary orthopedic implants industry, canine procedure volume continues to shape product development, training priorities, and inventory planning across almost every major supplier.

Cats are expected to record the fastest CAGR at 9.52% through 2031, which gives feline orthopedics the strongest growth profile among animal types. The American Pet Products Association reported a 23% increase in cat ownership in 2024, and that household shift is widening the patient base for feline fracture repair, stifle stabilization, and patellar luxation treatment. The American Veterinary Medical Association also showed owned cat numbers rising from 58.3 million to 76.3 million, which points to a larger and younger pool of future orthopedic candidates. Growth is also being helped by stronger owner willingness to authorize elective orthopedic work for cats, a category that historically lagged dogs in both recognition and treatment rates. Most current feline implants still adapt canine systems rather than fully purpose-built feline designs, which leaves a clear product gap for companies able to miniaturize without compromising biomechanical stability.

Complete Report Scope:

• By Product Type
  • Plates
    • Locking Compression Plates
    • Locking Distal Plates
    • Dynamic Compression Plates
    • Reconstruction Plates
    • TPLO Plates
    • TTA Plates
  • Screws
    • Bone Screws
    • Cortical Screws
    • Cancellous Screws
    • Locking Screws
    • Cannulated Screws
  • Pins and Wires
    • Intramedullary Pins
    • Kirschner Wires
  • Total Elbow Replacement Implants
  • Total Hip Replacement Implants
  • Total Knee Replacement Implants
  • Fixation Systems
  • Other Product Types
• By Animal Type
  • Dog
  • Cat
  • Horses
  • Other Animals
• By Material Type
  • Titanium
  • Stainless Steel
  • Bioabsorbable Polymers
  • Other Materials
• By Application
  • Trauma Fixation
  • Joint Replacement
  • Ligament Reconstruction
  • Osteoarthritis Management
  • Other Applications
• By End User
  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Surgical Centers
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 41.22% of revenue in 2025, which gave it the leading regional position in the Veterinary orthopedic implants market share. The region benefits from high pet healthcare spending, dense specialist referral networks, and a large insured companion animal base that supports acceptance of high-value surgery. NAPHIA reported USD 4.7 billion in U.S. pet insurance gross written premium in 2024 and projected more than USD 6 billion by the end of 2026, which gives North America a strong reimbursement tailwind for orthopedic procedures. APPA also reported U.S. pet industry expenditures of USD 158 billion in 2025 and USD 165 billion in 2026, with veterinary services capturing the fastest-growing share, which reinforces the region’s spending depth. Europe remains the second-largest regional block, while South America is smaller and still constrained by affordability and specialist availability even as urban pet ownership rises.

Europe’s position in the Veterinary orthopedic implants market rests on mature referral pathways and a tighter regulatory environment that increasingly rewards established quality systems. The EU Medical Device Regulation is raising expectations around biocompatibility documentation and post-market surveillance for implants traded across member states, which creates a higher compliance burden for smaller producers and a stronger moat for better-resourced suppliers. The region also benefits from strong veterinary surgery ecosystems in Germany, the United Kingdom, France, and Switzerland, where surgeon-led product development and structured referral channels support premium fixation and reconstruction demand. This makes Europe a market where procedural sophistication and regulatory discipline move together rather than in separate tracks.

Asia-Pacific is projected to expand at a 9.65% CAGR through 2031, giving it the fastest growth profile in the Veterinary orthopedic implants market size. China, Japan, India, Australia, and South Korea remain the core demand centers because they combine rising companion animal spending with ongoing investment in veterinary hospitals and specialist education. Urbanization and middle-class expansion are widening acceptance of advanced orthopedic care, especially in companion animal segments where owners are increasingly willing to pay for mobility-restoring procedures. The Middle East and Africa are developing from a smaller base, but GCC countries are building higher-end hospital capacity around equine medicine and premium pet ownership. India also stands out as a dual opportunity because it offers both expanding domestic demand for affordable fixation systems and a manufacturing base that can support export-oriented supply into neighboring regions.

List of Companies Covered in this Report:

• Arthrex Vet Systems
• Auxein Medical
• B. Braun
• BioMedtrix LLC
• BlueSAO Co., Ltd.
• Johnson & Johnson
• Fusion Implants
• GerVetUSA Inc.
• IMEX Veterinary, Inc.
• Innoplant Medizintechnik GmbH
• Integra LifeSciences
• Intrauma S.p.A.
• KYON AG
• Movora
• Narang Medical
• New Generation Devices, Inc.
• Orthomed (UK) Ltd.
• Rita Leibinger GmbH and Co. KG
• Securos Surgical
• Veterinary Instrumentation
• Veterinary Orthopedic Implants
• Vimian Group AB

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support